Literature DB >> 21608336

Outcome of untreated meningiomas.

Giorgio Rubin1, Zvi Herscovici, Yosef Laviv, Steve Jackson, Zvi H Rappaport.   

Abstract

BACKGROUND: Nowadays meningiomas are frequently detected incidentally. Their natural history has not yet been established because it is difficult to predict the growth pattern. Therefore, the management, after the radiological diagnosis, is still controversial.
OBJECTIVES: To evaluate the clinical outcome and growth rate of conservatively treated meningiomas at our tertiary center, identify prognostic factors of tumor growth, and suggest guidelines based on the available data and our experience.
METHODS: We reviewed the clinical records of 56 patients with 63 untreated meningiomas. Most were diagniosed incidentally. Clinical features and imaging findings at diagnosis and during follow-up were compared between growing and non-growing tumors. Potential patient- and tumor-related predictive factors for growth were analyzed.
RESULTS: The study group included 46 women (52 meningiomas) and 10 men (11 meningiomas) aged 39-83 years. Mean tumor size was 18 +/- 11 mm (range 3-70 mm) at diagnosis and 22 +/- 11 mm (range 8-70 mm) at last follow-up; mean follow-up time was 65 +/- 34 months (range 15-152 months). During follow-up 24 tumors (38%) grew ata rate of 4 mm per year; none became symptomatic. Only two prognostic factors were statistically significantly associated with low growth rate: older age and tumor calcifications.
CONCLUSIONS: Given our finding of a low growth incidence of meningiomas in the elderly, we support conservative management in patients aged 70 years or older. Calcifications into the meningioma are also indicative of slow growth, suggesting a conservative strategy. Surgery is recommended in younger patients in whom tumor growth occurs more often and a longer follow-up is necessary.

Entities:  

Mesh:

Year:  2011        PMID: 21608336

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  11 in total

1.  Clinical features and surgical management of intracranial meningiomas in the elderly.

Authors:  Junkoh Yamamoto; Mayu Takahashi; Masaru Idei; Yoshiteru Nakano; Yoshiteru Soejima; Daisuke Akiba; Takehiro Kitagawa; Kunihiro Ueta; Ryo Miyaoka; Shigeru Nishizawa
Journal:  Oncol Lett       Date:  2017-05-16       Impact factor: 2.967

2.  Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance.

Authors:  Camila Batista de Oliveira Silva; Bárbara Roberta Ongaratti; Geraldine Trott; Taiana Haag; Nelson Pires Ferreira; Carolina Garcia Soares Leães; Julia Fernanda Semmelmann Pereira-Lima; Miriam da Costa Oliveira
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Prediction of Histological Grade and Completeness of Resection of Intracranial Meningiomas: Role of Peritumoural Brain Edema.

Authors:  Kamalanathan Palaniandy; Mohammad Saffari Mohammad Haspani; Norzaini Rose Mohd Zain
Journal:  Malays J Med Sci       Date:  2017-06-30

4.  Outcomes from treatment of asymptomatic skull base meningioma with stereotactic radiosurgery.

Authors:  Stylianos Pikis; Adomas Bunevicius; Jason Sheehan
Journal:  Acta Neurochir (Wien)       Date:  2020-11-19       Impact factor: 2.216

Review 5.  Meningioma.

Authors:  Ali-Reza Fathi; Ulrich Roelcke
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

6.  Stereotactic radiosurgery versus active surveillance for asymptomatic, skull-based meningiomas: an international, multicenter matched cohort study.

Authors:  Georgios Mantziaris; Stylianos Pikis; Yavuz Samanci; Selcuk Peker; Ahmed M Nabeel; Wael A Reda; Sameh R Tawadros; Amr M N El-Shehaby; Khaled Abdelkarim; Reem M Emad; Violaine Delabar; David Mathieu; Cheng-Chia Lee; Huai-Che Yang; Roman Liscak; Jaromir Hanuska; Roberto Martinez Alvarez; Nuria Martinez Moreno; Manjul Tripathi; Herwin Speckter; Camilo Albert; Ronald J Benveniste; Greg N Bowden; Dev N Patel; Douglas Kondziolka; Kenneth Bernstein; L Dade Lunsford; Michael D Jenkinson; Abdurrahman I Islim; Jason Sheehan
Journal:  J Neurooncol       Date:  2022-01-24       Impact factor: 4.130

7.  Simultaneous analysis of miRNA-mRNA in human meningiomas by integrating transcriptome: A relationship between PTX3 and miR-29c.

Authors:  Altay Burak Dalan; Sukru Gulluoglu; Emre Can Tuysuz; Aysegul Kuskucu; Cumhur Kaan Yaltirik; Oguz Ozturk; Ugur Ture; Omer Faruk Bayrak
Journal:  BMC Cancer       Date:  2017-03-21       Impact factor: 4.430

8.  Natural History of Meningiomas: Review with Meta-analyses.

Authors:  Satoshi Nakasu; Yoko Nakasu
Journal:  Neurol Med Chir (Tokyo)       Date:  2020-01-31       Impact factor: 1.742

9.  A prospective study of the natural history of incidental meningioma-Hold your horses!

Authors:  Maziar Behbahani; Geir Olve Skeie; Geir Egil Eide; Annbjørg Hausken; Morten Lund-Johansen; Bente Sandvei Skeie
Journal:  Neurooncol Pract       Date:  2019-04-17

10.  Mysterious meningioma: Surviving the odds.

Authors:  Vangala Bramhaprasad; Alugolu Rajesh; Ashish Kumar
Journal:  Surg Neurol Int       Date:  2013-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.